Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous nephropathy-fortuitous or causal?

Kidney Int. 2023 Feb;103(2):425-427. doi: 10.1016/j.kint.2022.11.008.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Autoantibodies
  • Causality
  • Complementary Therapies*
  • Glomerulonephritis, Membranous*
  • Humans
  • Receptors, Phospholipase A2

Substances

  • Receptors, Phospholipase A2
  • Autoantibodies